{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T14:16:47Z","timestamp":1766067407785,"version":"3.48.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23068-x","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:37:11Z","timestamp":1765805831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Memantine treatment improves opioid-induced hyperalgesia symptoms: randomize clinical trial"],"prefix":"10.1038","volume":"15","author":[{"given":"Afagh","family":"Anjomshoaa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Zolghadriha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nafiseh Sadat","family":"Haj-seyed-taghia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omid","family":"Saed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Faghihzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"issue":"1","key":"23068_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-019-0137-5","volume":"6","author":"J Strang","year":"2020","unstructured":"Strang, J. et al. Opioid use disorder. Nat. Reviews Disease Primers. 6 (1), 3 (2020).","journal-title":"Nat. Reviews Disease Primers"},{"key":"23068_CR2","unstructured":"World Drug Report. (2023). https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2023.html"},{"key":"23068_CR3","doi-asserted-by":"crossref","unstructured":"Judd, D., King, C. R. & Galke, C. The opioid epidemic: a review of the contributing factors, negative consequences, and best practices. Cureus 15(7), e41621 (2023).","DOI":"10.7759\/cureus.41621"},{"key":"23068_CR4","doi-asserted-by":"crossref","unstructured":"Edinoff, A. N. et al. Physiological Considerations in Opioid Addictionp. 177\u2013184 (Elsevier, 2023).","DOI":"10.1016\/B978-0-323-98814-8.00029-9"},{"issue":"7","key":"23068_CR5","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s00210-023-02444-2","volume":"396","author":"K Podkowa","year":"2023","unstructured":"Podkowa, K., Czarnacki, K., Boro\u0144czyk, A., Boro\u0144czyk, M. & Paprocka, J. The NMDA receptor antagonists memantine and ketamine as anti-migraine agents. Naunyn. Schmiedebergs Arch. Pharmacol. 396 (7), 1371\u20131398 (2023).","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"23068_CR6","doi-asserted-by":"publisher","first-page":"1297931","DOI":"10.3389\/fphar.2023.1297931","volume":"14","author":"M Echeverria-Villalobos","year":"2023","unstructured":"Echeverria-Villalobos, M. et al. The role of neuroinflammation in the transition of acute to chronic pain and the opioid-induced hyperalgesia and tolerance. Front. Pharmacol. 14, 1297931 (2023).","journal-title":"Front. Pharmacol."},{"issue":"2","key":"23068_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/jpm10020027","volume":"10","author":"G Vargas-Schaffer","year":"2020","unstructured":"Vargas-Schaffer, G., Paquet, S., Neron, A. & Cogan, J. Opioid induced hyperalgesia, a research phenomenon or a clinical reality? Results of a Canadian survey. J. Personalized Med. 10 (2), 27 (2020).","journal-title":"J. Personalized Med."},{"issue":"3","key":"23068_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.5055\/jom.2008.0017","volume":"4","author":"S Mitra","year":"2008","unstructured":"Mitra, S. Opioid-induced hyperalgesia: pathophysiology and clinical implications. J. Opioid Manag. 4 (3), 123\u2013130 (2008).","journal-title":"J. Opioid Manag."},{"issue":"30s","key":"23068_CR9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.63682\/jns.v14i30S.7038","volume":"14","author":"K Serani","year":"2025","unstructured":"Serani, K. et al. Mechanisms of opioid-induced hyperalgesia: implications for chronic pain management. J. Neonatal Surg. 14 (30s), 729\u2013745 (2025).","journal-title":"J. Neonatal Surg."},{"issue":"5","key":"23068_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/ijpp\/riac031","volume":"30","author":"CK Svensson","year":"2022","unstructured":"Svensson, C. K. Opioid-induced hyperalgesia: is it a clinically relevant phenomenon? Int. J. Pharm. Pract. 30 (5), 479\u2013483 (2022).","journal-title":"Int. J. Pharm. Pract."},{"issue":"4","key":"23068_CR11","doi-asserted-by":"publisher","first-page":"e14638","DOI":"10.1111\/cbdd.14638","volume":"104","author":"YP Singh","year":"2024","unstructured":"Singh, Y. P. & Kumar, H. Recent advances in medicinal chemistry of memantine against alzheimer\u2019s disease. Chem. Biol. Drug Des. 104 (4), e14638 (2024).","journal-title":"Chem. Biol. Drug Des."},{"key":"23068_CR12","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jot.2024.08.007","volume":"48","author":"Q Cheng","year":"2024","unstructured":"Cheng, Q. et al. Memantine attenuates the development of osteoarthritis by blocking NMDA receptor mediated calcium overload and chondrocyte senescence. J. Orthop. Translation. 48, 204\u2013216 (2024).","journal-title":"J. Orthop. Translation"},{"issue":"2","key":"23068_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ejphar.2009.09.056","volume":"626","author":"JL Hay","year":"2010","unstructured":"Hay, J. L., Kaboutari, J., White, J. M., Salem, A. & Irvine, R. Model of methadone-induced hyperalgesia in rats and effect of memantine. Eur. J. Pharmacol. 626 (2), 229\u2013233 (2010).","journal-title":"Eur. J. Pharmacol."},{"key":"23068_CR14","doi-asserted-by":"crossref","unstructured":"Shanthanna, H. & Memantine Features and Application in the Management of Chronic pain. treatments, mechanisms, and Adverse Reactions of Anesthetics and Analgesicsp. 121\u2013130 (Elsevier, 2022).","DOI":"10.1016\/B978-0-12-820237-1.00013-2"},{"issue":"10","key":"23068_CR15","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1007\/s11136-023-03411-3","volume":"32","author":"M \u00c5str\u00f6m","year":"2023","unstructured":"\u00c5str\u00f6m, M., Thet Lwin, Z. M., Teni, F. S., Burstr\u00f6m, K. & Berg, J. Use of the visual analogue scale for health state valuation: a scoping review. Qual. Life Res. 32 (10), 2719\u20132729 (2023).","journal-title":"Qual. Life Res."},{"issue":"6","key":"23068_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/AJP.0b013e31816b2f43","volume":"24","author":"LF Chu","year":"2008","unstructured":"Chu, L. F., Angst, M. S. & Clark, D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin. J. Pain. 24 (6), 479\u2013496 (2008).","journal-title":"Clin. J. Pain"},{"key":"23068_CR17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00213-007-0998-2","volume":"196","author":"AC Harris","year":"2008","unstructured":"Harris, A. C., Rothwell, P. E. & Gewirtz, J. C. Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia. Psychopharmacology 196, 649\u2013660 (2008).","journal-title":"Psychopharmacology"},{"issue":"1","key":"23068_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0885-3924(99)00121-9","volume":"19","author":"DD Price","year":"2000","unstructured":"Price, D. D., Mayer, D. J., Mao, J. & Caruso, F. S. NMDA-receptor antagonists and opioid receptor interactions as related to analgesia and tolerance. J. Pain Symptom Manag. 19 (1), 7\u201311 (2000).","journal-title":"J. Pain Symptom Manag."},{"issue":"6","key":"23068_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2165\/00002512-200320060-00005","volume":"20","author":"B Jarvis","year":"2003","unstructured":"Jarvis, B. & Figgitt, D. P. Memantine Drugs Aging ;20(6):465\u2013476. (2003).","journal-title":"Memantine Drugs Aging"},{"issue":"3\u20134","key":"23068_CR20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/19371918.2013.759031","volume":"28","author":"AB Douaihy","year":"2013","unstructured":"Douaihy, A. B., Kelly, T. M. & Sullivan, C. Medications for substance use disorders. Social Work public. Health. 28 (3\u20134), 264\u2013278 (2013).","journal-title":"Social Work public. Health"},{"issue":"2","key":"23068_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/medicina60020285","volume":"60","author":"M Bonanno","year":"2024","unstructured":"Bonanno, M., Papa, D., Cerasa, A., Maggio, M. G. & Calabr\u00f2, R. S. Psycho-neuroendocrinology in the rehabilitation field: focus on the complex interplay between stress and pain. Medicina 60 (2), 285 (2024).","journal-title":"Medicina"},{"key":"23068_CR22","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1016\/0003-9969(94)90189-9","volume":"39","author":"PA McGrath","year":"1994","unstructured":"McGrath, P. A. Psychological aspects of pain perception. Arch. Oral Biol. 39, S55\u2013S62 (1994).","journal-title":"Arch. Oral Biol."},{"issue":"7","key":"23068_CR23","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/ejp.1393","volume":"23","author":"R Kurian","year":"2019","unstructured":"Kurian, R., Raza, K. & Shanthanna, H. A systematic review and meta-analysis of memantine for the prevention or treatment of chronic pain. Eur. J. Pain. 23 (7), 1234\u20131250 (2019).","journal-title":"Eur. J. Pain"},{"key":"23068_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jsat.2019.10.003","volume":"107","author":"AM Elias","year":"2019","unstructured":"Elias, A. M., Pepin, M. J. & Brown, J. N. Adjunctive memantine for opioid use disorder treatment: A systematic review. J. Subst. Abuse Treat. 107, 38\u201343 (2019).","journal-title":"J. Subst. Abuse Treat."},{"issue":"S1","key":"23068_CR25","doi-asserted-by":"publisher","first-page":"S328","DOI":"10.1192\/bjo.2025.10795","volume":"11","author":"H Kaur","year":"2025","unstructured":"Kaur, H. & Sharma, S. Memantine in psychiatry: an underutilized therapeutic breakthrough? BJPsych Open. 11 (S1), S328\u2013S (2025).","journal-title":"BJPsych Open."},{"issue":"5","key":"23068_CR26","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3390\/ph18050700","volume":"18","author":"K Eskandari","year":"2025","unstructured":"Eskandari, K., B\u00e9langer, S-M., Lachance, V. & Kourrich, S. Repurposing sigma-1 receptor-targeting drugs for therapeutic advances in neurodegenerative disorders. Pharmaceuticals 18 (5), 700 (2025).","journal-title":"Pharmaceuticals"},{"issue":"6","key":"23068_CR27","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1007\/s43440-021-00310-7","volume":"73","author":"A Piechal","year":"2021","unstructured":"Piechal, A., Jakimiuk, A. & Mirowska-Guzel, D. Sigma receptors and neurological disorders. Pharmacol. Rep. 73 (6), 1582\u20131594 (2021).","journal-title":"Pharmacol. Rep."},{"issue":"2","key":"23068_CR28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","volume":"129","author":"R-R Ji","year":"2018","unstructured":"Ji, R-R., Nackley, A., Huh, Y., Terrando, N. & Maixner, W. Neuroinflammation and central sensitization in chronic and widespread pain. Anesthesiology 129 (2), 343 (2018).","journal-title":"Anesthesiology"},{"key":"23068_CR29","unstructured":"https:\/\/irct.behdasht.gov.ir\/trial\/60058 2021-12-07."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23068-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23068-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23068-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T14:08:45Z","timestamp":1766066925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23068-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23068"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23068-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"2 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study adhered to ethical guidelines. The protocol was approved by the Ethics Committee of Zanjan University of Medical Sciences (IR.ZUMS.REC.1400.264). Informed consent was obtained from all participants, ensuring the privacy and confidentiality of their information. All procedures followed the ethical standards set forth by the Regional Research Committee and the Declaration of Helsinki (1964 and later amendments). The study was registered with the registration number IRCT20211112053045N1 on 07\/12\/2021, and the registration details are available at the IRCT website:\n                      \n                      29\n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"43890"}}